KEMPHARM INC's ticker is KMPH and the CUSIP is 488445107. A total of 38 filers reported holding KEMPHARM INC in Q1 2019. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $44,000 | -70.3% | 196,997 | -50.0% | 0.00% | – |
Q4 2019 | $148,000 | +9.6% | 393,994 | +100.0% | 0.00% | – |
Q3 2019 | $135,000 | -60.8% | 196,997 | 0.0% | 0.00% | – |
Q2 2019 | $344,000 | +20.7% | 196,997 | +15.2% | 0.00% | – |
Q1 2019 | $285,000 | -53.1% | 171,047 | -50.0% | 0.00% | – |
Q4 2018 | $608,000 | +75.7% | 342,094 | +373.3% | 0.00% | – |
Q3 2018 | $346,000 | -26.2% | 72,272 | 0.0% | 0.00% | – |
Q2 2018 | $469,000 | -12.0% | 72,272 | +7.0% | 0.00% | – |
Q1 2018 | $533,000 | +95.2% | 67,567 | 0.0% | 0.00% | – |
Q4 2017 | $273,000 | +9.6% | 67,567 | 0.0% | 0.00% | – |
Q3 2017 | $249,000 | -7.8% | 67,567 | 0.0% | 0.00% | – |
Q2 2017 | $270,000 | -20.6% | 67,567 | -2.8% | 0.00% | – |
Q1 2017 | $340,000 | +66.7% | 69,510 | +0.4% | 0.00% | – |
Q4 2016 | $204,000 | -34.2% | 69,246 | +0.3% | 0.00% | – |
Q3 2016 | $310,000 | +82.4% | 69,070 | +61.2% | 0.00% | – |
Q2 2016 | $170,000 | -65.9% | 42,856 | +24.5% | 0.00% | – |
Q1 2016 | $499,000 | -27.0% | 34,435 | -0.1% | 0.00% | – |
Q4 2015 | $684,000 | +6.2% | 34,479 | +3.7% | 0.00% | – |
Q3 2015 | $644,000 | – | 33,236 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 4,095,914 | $6,840,000 | 1.26% |
Arete Wealth Advisors, LLC | 497,606 | $831,000 | 0.17% |
COWEN INC. | 438,505 | $732,000 | 0.08% |
Alyeska Investment Group, L.P. | 1,502,846 | $2,510,000 | 0.03% |
NORTHWEST WEALTH MANAGEMENT, LLC | 16,070 | $27,000 | 0.02% |
Iowa State Bank | 23,171 | $39,000 | 0.02% |
CreativeOne Wealth, LLC | 37,667 | $63,000 | 0.02% |
Sound Income Strategies, LLC | 10,000 | $17,000 | 0.01% |
WEDBUSH SECURITIES INC | 43,265 | $72,000 | 0.01% |
Evanson Asset Management, LLC | 17,094 | $29,000 | 0.01% |